Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support?

Mol Psychiatry. 2006 Dec;11(12):1113-5. doi: 10.1038/sj.mp.4001913. Epub 2006 Oct 10.

Abstract

Hematopoietic stem cells contribute to mammalian brain tissue regeneration by transdifferentiation processes. We found decreased counts of circulating CD34+ cells in early Alzheimer's dementia (AD; P = 0.01), which significantly correlated with age (r = -0.661; P = 0.001), cerebrospinal fluid beta-amyloid (Abeta)1-42 (r = -0.467; P = 0.025) and most pronounced the Abeta42/40 ratio (r = -0.688; P = 0.005). Our data suggest a deficient regenerative hematopoietic support for the central nervous system in early AD.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / blood*
  • Alzheimer Disease / cerebrospinal fluid*
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Antigens, CD34 / blood*
  • Female
  • Hematopoiesis*
  • Humans
  • Male
  • Regeneration*
  • Stem Cells*

Substances

  • Amyloid beta-Peptides
  • Antigens, CD34